Binding of anti-prion agents to glycosaminoglycans

Evidence from electronic absorption and circular dichroism spectroscopy

F. Zsila, Gábor Gedeon

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

The polyanionic glycosaminoglycans (GAGs) are intimately involved in the pathogenesis of protein conformational disorders such as amyloidosis and prion diseases. Several cationic agents are known to exhibit anti-prion activity but their mechanism of action is poorly understood. In this study, UV absorption and circular dichroism (CD) spectroscopic techniques were used to investigate the interaction between heparin and chondroitin-6-sulfate and anti-prion drugs including acridine, quinoline, and phenothiazine derivatives. UV band hypochromism of (±)-quinacrine, (±)-primaquine, tacrine, quinidine, chlorpromazine, and induced CD spectra of (±)-quinacrine upon addition of GAGs provided evidence for the GAG binding of these compounds. The association constants (∼106-107 M-1) estimated from the UV titration curves show high-affinity drug-heparin interactions. Ionic strength-dependence of the absorption spectra suggested that the interaction between GAGs and the cationic drugs is principally electrostatic in nature. Drug binding differences of heparin and chondroitin-6-sulfate were attributed to their different negative charge density. These results call the attention to the alteration of GAG-prion/GAG-amyloid interactions by which these compounds might exert their anti-prion/anti-amyloidogenic activities.

Original languageEnglish
Pages (from-to)1267-1274
Number of pages8
JournalBiochemical and Biophysical Research Communications
Volume346
Issue number4
DOIs
Publication statusPublished - Aug 11 2006

Fingerprint

Circular dichroism spectroscopy
Prions
Circular Dichroism
Glycosaminoglycans
Spectrum Analysis
Heparin
Quinacrine
Chondroitin Sulfates
Pharmaceutical Preparations
Primaquine
Acridines
Tacrine
Prion Diseases
Quinidine
Chlorpromazine
Amyloidosis
Ionic strength
Charge density
Static Electricity
Titration

Keywords

  • Amyloid
  • Chlorpromazine
  • Chondroitin-6-sulfate
  • Circular dichroism spectroscopy
  • Glycosaminoglycans
  • Heparin
  • Hypochromism
  • Prion
  • Quinacrine

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

@article{2866976507b04af0b55d973b50ba748d,
title = "Binding of anti-prion agents to glycosaminoglycans: Evidence from electronic absorption and circular dichroism spectroscopy",
abstract = "The polyanionic glycosaminoglycans (GAGs) are intimately involved in the pathogenesis of protein conformational disorders such as amyloidosis and prion diseases. Several cationic agents are known to exhibit anti-prion activity but their mechanism of action is poorly understood. In this study, UV absorption and circular dichroism (CD) spectroscopic techniques were used to investigate the interaction between heparin and chondroitin-6-sulfate and anti-prion drugs including acridine, quinoline, and phenothiazine derivatives. UV band hypochromism of (±)-quinacrine, (±)-primaquine, tacrine, quinidine, chlorpromazine, and induced CD spectra of (±)-quinacrine upon addition of GAGs provided evidence for the GAG binding of these compounds. The association constants (∼106-107 M-1) estimated from the UV titration curves show high-affinity drug-heparin interactions. Ionic strength-dependence of the absorption spectra suggested that the interaction between GAGs and the cationic drugs is principally electrostatic in nature. Drug binding differences of heparin and chondroitin-6-sulfate were attributed to their different negative charge density. These results call the attention to the alteration of GAG-prion/GAG-amyloid interactions by which these compounds might exert their anti-prion/anti-amyloidogenic activities.",
keywords = "Amyloid, Chlorpromazine, Chondroitin-6-sulfate, Circular dichroism spectroscopy, Glycosaminoglycans, Heparin, Hypochromism, Prion, Quinacrine",
author = "F. Zsila and G{\'a}bor Gedeon",
year = "2006",
month = "8",
day = "11",
doi = "10.1016/j.bbrc.2006.06.033",
language = "English",
volume = "346",
pages = "1267--1274",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - Binding of anti-prion agents to glycosaminoglycans

T2 - Evidence from electronic absorption and circular dichroism spectroscopy

AU - Zsila, F.

AU - Gedeon, Gábor

PY - 2006/8/11

Y1 - 2006/8/11

N2 - The polyanionic glycosaminoglycans (GAGs) are intimately involved in the pathogenesis of protein conformational disorders such as amyloidosis and prion diseases. Several cationic agents are known to exhibit anti-prion activity but their mechanism of action is poorly understood. In this study, UV absorption and circular dichroism (CD) spectroscopic techniques were used to investigate the interaction between heparin and chondroitin-6-sulfate and anti-prion drugs including acridine, quinoline, and phenothiazine derivatives. UV band hypochromism of (±)-quinacrine, (±)-primaquine, tacrine, quinidine, chlorpromazine, and induced CD spectra of (±)-quinacrine upon addition of GAGs provided evidence for the GAG binding of these compounds. The association constants (∼106-107 M-1) estimated from the UV titration curves show high-affinity drug-heparin interactions. Ionic strength-dependence of the absorption spectra suggested that the interaction between GAGs and the cationic drugs is principally electrostatic in nature. Drug binding differences of heparin and chondroitin-6-sulfate were attributed to their different negative charge density. These results call the attention to the alteration of GAG-prion/GAG-amyloid interactions by which these compounds might exert their anti-prion/anti-amyloidogenic activities.

AB - The polyanionic glycosaminoglycans (GAGs) are intimately involved in the pathogenesis of protein conformational disorders such as amyloidosis and prion diseases. Several cationic agents are known to exhibit anti-prion activity but their mechanism of action is poorly understood. In this study, UV absorption and circular dichroism (CD) spectroscopic techniques were used to investigate the interaction between heparin and chondroitin-6-sulfate and anti-prion drugs including acridine, quinoline, and phenothiazine derivatives. UV band hypochromism of (±)-quinacrine, (±)-primaquine, tacrine, quinidine, chlorpromazine, and induced CD spectra of (±)-quinacrine upon addition of GAGs provided evidence for the GAG binding of these compounds. The association constants (∼106-107 M-1) estimated from the UV titration curves show high-affinity drug-heparin interactions. Ionic strength-dependence of the absorption spectra suggested that the interaction between GAGs and the cationic drugs is principally electrostatic in nature. Drug binding differences of heparin and chondroitin-6-sulfate were attributed to their different negative charge density. These results call the attention to the alteration of GAG-prion/GAG-amyloid interactions by which these compounds might exert their anti-prion/anti-amyloidogenic activities.

KW - Amyloid

KW - Chlorpromazine

KW - Chondroitin-6-sulfate

KW - Circular dichroism spectroscopy

KW - Glycosaminoglycans

KW - Heparin

KW - Hypochromism

KW - Prion

KW - Quinacrine

UR - http://www.scopus.com/inward/record.url?scp=33745333934&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745333934&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2006.06.033

DO - 10.1016/j.bbrc.2006.06.033

M3 - Article

VL - 346

SP - 1267

EP - 1274

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 4

ER -